The founder of Andaman7’s leukemia diagnosis, and his son’s experience with bone cancer, have helped inform the firm's tech and patient-centric approach.

When life-science tech outfit is looking to build new product offerings or refine existing tech, their work can benefit from drawing patient points of view and experiences. That's something that Vincent Keunen, CEO and founder of Andaman7, knows all too well - in 2007, he was diagnosed with leukemia and his son with bone cancer just three months later. 

Outsourcing-Pharma (OSP) recently spoke with Keunen (VK) about his family's experiences with cancer, and the unique perspective patients can offer clinical trials their technology providers.  

See the article here